Ann Rheum Dis. 2000 Nov;59 Suppl 1:i85-9.

Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences.

Braun J, Xiang J, Brandt J, Maetzel H, Haibel H, Wu P, Kohler S, Rudwaleit M, Siegert S, Radbruch A, Thiel A, Sieper J.

Source

Department of Medicine, Rheumatology, Benjamin Franklin Hospital, Free University Berlin, and German Rheumatology Research Centre, Berlin, Germany. jbraun@zedat.fu-berlin.de

PMID:: 11053096; [PubMed - indexed for MEDLINE]
PMCID:: PMC1766610

Free PMC Article

Images from this publication.See all images (3) Free text

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Bone Infections - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Assessment of patients with spondyloarthropathies for treatment with tumour necrosis factor alpha blockade. [Rheumatology (Oxford). 2005]
Review Assessment of patients with spondyloarthropathies for treatment with tumour necrosis factor alpha blockade.
Paul S, Keat A. Rheumatology (Oxford). 2005 Jan; 44(1):17-23. Epub 2004 Aug 24.
Anti-TNFalpha: a new dimension in the pharmacotherapy of the spondyloarthropathies !? [Ann Rheum Dis. 2000]
Anti-TNFalpha: a new dimension in the pharmacotherapy of the spondyloarthropathies !?
Braun J, Sieper J. Ann Rheum Dis. 2000 Jun; 59(6):404-7.
Anti-tumour necrosis factor therapy in ankylosing spondylitis. A need for guidelines. [Rheumatology (Oxford). 2003]
Anti-tumour necrosis factor therapy in ankylosing spondylitis. A need for guidelines.
Kassimos DG, Garyfallos A, Delamere J, Whallett A, Kitas GD. Rheumatology (Oxford). 2003 Mar; 42(3):490.
Review New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy. [Curr Opin Rheumatol. 2001]
Review New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy.
Braun J, de Keyser F, Brandt J, Mielants H, Sieper J, Veys E. Curr Opin Rheumatol. 2001 Jul; 13(4):245-9.
Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis? [Ann Rheum Dis. 2008]
Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis?
Gaspersic N, Sersa I, Jevtic V, Tomsic M, Praprotnik S. Ann Rheum Dis. 2008 Sep; 67(9):1354.

See reviews... See all...

Cited by 6 PubMed Central articles

Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis. [Ann Rheum Dis. 2006]
Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis.
Boonen A, van der Heijde D, Severens JL, Boendermaker A, Landewé R, Braun J, Brandt J, Sieper J, van der Linden S. Ann Rheum Dis. 2006 Feb; 65(2):201-8. Epub 2005 Jul 13.
Review Expanding the armamentarium for the spondyloarthropathies. [Arthritis Res Ther. 2004]
Review Expanding the armamentarium for the spondyloarthropathies.
Peloso PM, Braun J. Arthritis Res Ther. 2004; 6 Suppl 2:S36-43. Epub 2004 Jun 21.
Review Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review. [Ann Rheum Dis. 2003]
Review Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review.
Keller C, Webb A, Davis J. Ann Rheum Dis. 2003 Dec; 62(12):1128-32.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Treatment of spondyloarthropathies with antibodies against tumour necrosis facto...
Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences.
Ann Rheum Dis. 2000 Nov ;59 Suppl 1:i85-9.

PubMed
Secretion of extracellular superoxide dismutase in neonatal lungs.
Secretion of extracellular superoxide dismutase in neonatal lungs.
Am J Physiol Lung Cell Mol Physiol. 2000 Nov ;279(5):L977-84.

PubMed
Influence of relative humidity on particle size and UV sensitivity of Serratia m...
Influence of relative humidity on particle size and UV sensitivity of Serratia marcescens and Mycobacterium bovis BCG aerosols.
Tuber Lung Dis. 2000 ;80(4-5):217-28.

PubMed
Tetrahydro-beta-carbolines, potential neuroactive alkaloids, in chocolate and co...
Tetrahydro-beta-carbolines, potential neuroactive alkaloids, in chocolate and cocoa.
J Agric Food Chem. 2000 Oct ;48(10):4900-4.

PubMed
Adverse effects of antiretroviral therapy.
Adverse effects of antiretroviral therapy.
Lancet. 2000 Oct 21 ;356(9239):1423-30.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: